BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21920017)

  • 1. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients.
    Avolio AW; Cillo U; Salizzoni M; De Carlis L; Colledan M; Gerunda GE; Mazzaferro V; Tisone G; Romagnoli R; Caccamo L; Rossi M; Vitale A; Cucchetti A; Lupo L; Gruttadauria S; Nicolotti N; Burra P; Gasbarrini A; Agnes S;
    Am J Transplant; 2011 Dec; 11(12):2724-36. PubMed ID: 21920017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing predictors of graft survival in patients undergoing liver transplantation with donors aged 70 years and over.
    Caso-Maestro O; Jiménez-Romero C; Justo-Alonso I; Calvo-Pulido J; Lora-Pablos D; Marcacuzco-Quinto A; Cambra-Molero F; García-Sesma A; Pérez-Flecha M; Muñoz-Arce C; Loinaz-Segurola C; Manrique-Municio A
    World J Gastroenterol; 2018 Dec; 24(47):5391-5402. PubMed ID: 30598583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.
    Vitale A; Ramirez Morales R; dalla Bona E; Scopelliti M; Zanus G; Neri D; d'Amico F; Gringeri E; Russo F; Burra P; Angeli P; Cillo U
    Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.
    Tanemura A; Mizuno S; Kato H; Murata Y; Kuriyama N; Azumi Y; Kishiwada M; Usui M; Sakurai H; Isaji S
    Transplant Proc; 2016 May; 48(4):1025-31. PubMed ID: 27320548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.
    Lanini S; Nanni Costa A; Grossi PA; Procaccio F; Ricci A; Capobianchi MR; Terrault NA; Ippolito G
    Liver Int; 2016 Mar; 36(3):410-7. PubMed ID: 26264452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index.
    Biggins SW; Gralla J; Dodge JL; Bambha KM; Tong S; Barón AE; Inadomi J; Terrault N; Rosen HR
    Am J Transplant; 2014 Nov; 14(11):2588-94. PubMed ID: 25243648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The corrected donor age for hepatitis C virus-infected liver transplant recipients.
    Dirchwolf M; Dodge JL; Gralla J; Bambha KM; Nydam T; Hung KW; Rosen HR; Feng S; Terrault NA; Biggins SW
    Liver Transpl; 2015 Aug; 21(8):1022-30. PubMed ID: 26074140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation.
    Soin AS; Goja S; Yadav SK; Tamang TY; Rastogi A; Bhangui P; Thiagrajan S; Raut V; Babu RY; Saigal S; Saraf N; Choudhary NS; Vohara V
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28239914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score.
    Hu Z; Zhou J; Li Z; Xiang J; Zhang Q; Yan S; Wu J; Zhang M; Wang W; Zheng S
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):206-216. PubMed ID: 28107613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.
    Cepeda-Franco C; Bernal-Bellido C; Barrera-Pulido L; Álamo-Martínez JM; Ruiz-Matas JH; Suárez-Artacho G; Marín-Gómez LM; Tinoco-González J; Díaz-Aunión C; Padillo-Ruiz FJ; Gómez-Bravo MÁ
    Transplant Proc; 2016 Nov; 48(9):2983-2986. PubMed ID: 27932125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ Transplantation Registry Data Analysis.
    Park H; Lee H; Baik S; Kim MS; Yang J; Jeong JC; Koo TY; Kim DG; Lee JM
    Ann Transplant; 2024 May; 29():e943588. PubMed ID: 38769724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation.
    Avolio AW; Agnes S; Cillo U; Lirosi MC; Romagnoli R; Baccarani U; Zamboni F; Nicolini D; Donataccio M; Perrella A; Ettorre GM; Romano M; Morelli N; Vennarecci G; de Waure C; Fagiuoli S; Burra P; Cucchetti A
    Transpl Int; 2012 Mar; 25(3):294-301. PubMed ID: 22268763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching.
    Halldorson JB; Bakthavatsalam R; Fix O; Reyes JD; Perkins JD
    Am J Transplant; 2009 Feb; 9(2):318-26. PubMed ID: 19120079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
    Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.
    Singh N; Neidlinger N; Djamali A; Leverson G; Voss B; Sollinger HW; Pirsch JD
    Clin Transplant; 2012; 26(5):684-93. PubMed ID: 22283142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
    Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
    Celik N; Kelly B; Soltys K; Squires JE; Vockley J; Shellmer DA; Strauss K; McKiernan P; Ganoza A; Sindhi R; Bond G; Mazariegos G; Khanna A
    Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.